Donna Peerboom, Johan De Coster, Kris Vanhaecht, Caroline Weltens, Inge Fourneau, Ans Verbert, Beate Bechter-Hugl, Boudewijn Moors, Bram Balduyck, Luis Carlos Silva Corten, Catherine Terry, Dominique De Roover, Edo Wijtenburg, Frank Depuydt, Frederic Libeer, Hozan Mufty, Inga Vanhandenhove, Jacques Demelenne, Jan De Letter, Jean-Paul Haxhe, Johan Duchateau, Jorn Robijn, Jos Vandekerkhof, Katrien Cuppens, Koen Deloose, Koen Van der Stock, Luc Janssen, Marc Vuylsteke, Mario Mattens, Maxime Elens, Michel Danneels, Ozan Yazar, Pascal Deridder, Patrick Lauwers, Patrick Stabel, Pauwel Bernaerts, Philippe Devleeschauwer, Pieter Van de Gender, Roel Beelen, Sabrina Houthoofd, Sarah Thomis, Stefan Stalpaert, Stephan Ceuppens, Stijn Schepers, Toon Sabbe, Erik Debing, Peter Goverde, Laura Kerselaers, Geert Lauwers, Philip Lerut, Philippe Remy, Katelijne Vanslembroek, Jurgen Verbist, Robert Verhelst, Frank Vermassen, Surgical clinical sciences, Cardio-vascular diseases, and Vascular surgery
BACKGROUND: The aim of the present study is to develop relevant quality indicators (QI) to monitor and improve quality of care in vascular surgery. METHODS: The Delphi method was used to incorporate expert opinion to reach consensus on a set of QI. A national expert panel consisting of 52 vascular surgeons was installed on a voluntary basis and endorsed by the Belgian Society of Vascular Surgery and the Flemish Hospital Network KU Leuven. A task force team consisting of 12 surgeons was created to serve as a delegation of the expert panel to discuss and filter the obtained data from the different Delphi rounds. RESULTS: A total of 3 Delphi rounds were needed to reach consensus on a set of 20 QI. Each QI had a content validity index (using a 7-point Likert scale), a feasibility index, and a target level. Twelve outcome indicators and 8 process indicators on several vascular topics were selected: overall for all vascular treatments (n = 1), arterial occlusive disease in general (n = 3), arterial occlusive disease of the lower limbs (n = 4), arterial occlusive disease of the carotid arteries (n = 5), arterial aneurysm disease in general (n = 2), arterial aneurysm disease with endovascular treatment (n = 1), and venous disease (n = 4). CONCLUSIONS: This resulted in the successful identification of 20 validated and relevant vascular QI, focusing on arterial occlusive disease, arterial aneurysm disease, and venous disease. The next step in this project will be the performance of an implementation study. ispartof: ANNALS OF VASCULAR SURGERY vol:71 pages:237-248 ispartof: location:Netherlands status: published